Orion Portfolio Solutions LLC decreased its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 12.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 73,044 shares of the company's stock after selling 10,444 shares during the quarter. Orion Portfolio Solutions LLC owned approximately 0.05% of Perrigo worth $1,878,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the business. Franklin Resources Inc. acquired a new position in shares of Perrigo during the third quarter valued at $3,717,000. Barclays PLC boosted its stake in Perrigo by 44.8% during the 3rd quarter. Barclays PLC now owns 120,502 shares of the company's stock valued at $3,160,000 after purchasing an additional 37,268 shares during the period. JPMorgan Chase & Co. grew its position in Perrigo by 65.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 541,000 shares of the company's stock worth $14,190,000 after purchasing an additional 213,221 shares during the last quarter. Citigroup Inc. increased its stake in shares of Perrigo by 94.1% in the third quarter. Citigroup Inc. now owns 151,520 shares of the company's stock valued at $3,974,000 after purchasing an additional 73,457 shares during the period. Finally, Virtu Financial LLC bought a new stake in shares of Perrigo during the third quarter valued at approximately $909,000. Institutional investors own 95.91% of the company's stock.
Insider Buying and Selling
In related news, EVP Ronald Craig Janish sold 7,800 shares of the stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.70% of the stock is currently owned by insiders.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on PRGO shares. Piper Sandler cut Perrigo from an "overweight" rating to a "neutral" rating and lowered their target price for the company from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a report on Wednesday, February 19th. Finally, Argus downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $33.00.
Check Out Our Latest Report on Perrigo
Perrigo Price Performance
NYSE PRGO traded down $0.29 on Monday, reaching $26.02. 2,804,978 shares of the stock traded hands, compared to its average volume of 1,513,100. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.46. The company has a quick ratio of 1.77, a current ratio of 2.56 and a debt-to-equity ratio of 0.94. The firm's fifty day simple moving average is $26.43 and its 200 day simple moving average is $26.13. The company has a market cap of $3.55 billion, a price-to-earnings ratio of -22.24 and a beta of 0.49.
Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.20 billion. As a group, research analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Investors of record on Friday, March 7th were paid a dividend of $0.29 per share. The ex-dividend date of this dividend was Friday, March 7th. This is a positive change from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 annualized dividend and a yield of 4.46%. Perrigo's dividend payout ratio is currently -92.80%.
About Perrigo
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Articles

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.